Publikationen, an denen er mitarbeitet José García Arumí (31)

2024

  1. Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study

    Eye (Basingstoke)

  2. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

2022

  1. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

    Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324

2020

  1. Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study

    Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829

2018

  1. Efficacy and safety of an aflibercept treat-and-extend regimen in treatment-naïve patients with macular oedema secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

    Journal of Ophthalmology, Vol. 2018

2017

  1. Telemedicine for a General Screening of Retinal Disease Using Nonmydriatic Fundus Cameras in Optometry Centers: Three-Year Results

    Telemedicine and e-Health, Vol. 23, Núm. 1, pp. 30-36

2015

  1. Management of Vision-Threatening Complications of Vasoproliferative Tumors of the Retina

    Ophthalmic Research, Vol. 54, Núm. 1, pp. 34-40

2012

  1. Posterior scleritis resembling acute retinal necrosis syndrome

    Retinal Cases and Brief Reports, Vol. 6, Núm. 1, pp. 102-104

  2. Vitreous levels of somatostatin in patients with chronic uveitic macular oedema

    Eye (Basingstoke), Vol. 26, Núm. 10, pp. 1378-1383

2011

  1. Macular holes after rhegmatogenous retinal detachment repair: Surgical management and functional outcome

    Retina, Vol. 31, Núm. 9, pp. 1777-1782

2010

  1. A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: The Retina 4 Project

    Ophthalmology, Vol. 117, Núm. 12

  2. Insulin resistance and diabetic macular oedema in type 2 diabetes mellitus

    British Journal of Ophthalmology, Vol. 94, Núm. 9, pp. 1230-1232

  3. Vitreous levels of interleukine-8 and monocyte chemoattractant protein-1 in macular oedema with branch retinal vein occlusion

    Eye, Vol. 24, Núm. 7, pp. 1284-1290

2009

  1. Erythropoietin and diabetic macular oedema

    Eye

  2. Estudio de mediadores patogénicos del edema macular diabético mediante análisis del humor vítreo: Papel de la eritropoyetina y la somatostatina

    Archivos de la Sociedad Española de Oftalmologia, Vol. 84, Núm. 12, pp. 591-594

  3. Ocular syphilisback again: Understanding recent increases in the incidence of ocular syphilitic disease

    Ocular Immunology and Inflammation, Vol. 17, Núm. 3, pp. 207-212

  4. Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: A comparative study with diabetic macular oedema (Eye (2009) 23, (1066-1071) DOI: 10.1038/eye.2008.230)

    Eye

2008

  1. An unusual case of fungal chorioretinitis in an immunocompetent individual

    Ocular Immunology and Inflammation, Vol. 16, Núm. 5-6, pp. 242-243

  2. Cirugía vitreorretiniana en el tratamiento de la retinopatía diabética proliferativa y el edema macular diabético

    Avances en diabetología, Vol. 24, Núm. 1, pp. 35-42

  3. Endoftalmitis crónicas postquirúrgicas

    Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears, Vol. 16, Núm. 5